SCHEMBL2919355

SCHEMBL2919355

NC(=O)N(CCO)Cc1cccc(CN(CCO)C(N)=O)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2D O15399 6/20 0.49
GRIN3B O60391 6/20 0.49
GRIN1 Q05586 6/20 0.49
GRIN2A Q12879 6/20 0.49
GRIN2B Q13224 6/20 0.49
GRIN2C Q14957 6/20 0.49
GRIN3A Q8TCU5 6/20 0.49
L3MBTL1 Q9Y468 1/20 0.42
ALDH1A1 P00352 3/20 0.40
HDAC3 O15379 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC7 Q8WUI4 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC10 Q969S8 1/20 0.40
HDAC11 Q96DB2 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
HDAC9 Q9UKV0 1/20 0.40
HDAC5 Q9UQL6 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28741972 0.87 L3MBTL1 (0.54) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL268819 0.84 L3MBTL1 (0.50) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL3900020 0.77 HDAC1 (0.53) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL3127288 0.77 BCHE (0.49) HDAC1HDAC6CYP3A4PTGES
SCHEMBL8391382 0.75 GRIN2D (0.57) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL2774547 0.74 HDAC3 (0.43) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL2810622 0.74 HDAC3 (0.43) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL2774550 0.74 HDAC3 (0.43) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL766565 0.73 L3MBTL1 (0.58) L3MBTL1ALDH1A1HDAC3HDAC4HDAC1
SCHEMBL3422890 0.73 MEN1 (0.56) L3MBTL1HDAC1HDAC6LMNALIMK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023250381-A2 ANTIBODIES TO BOTULINUM NEUROTOXINS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-12-28 WO disclosed
WO-2023201192-A2 ANTIBODIES TO BOTULINUM NEUROTOXINS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-10-19 WO disclosed
US-20230279084-A1 ANTIBODIES TO BOTULINUM NEUROTOXINS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2023-09-07 US disclosed
US-11505598-B2 Antibodies to botulinum neurotoxins THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2022-11-22 US disclosed
US-20220089784-A1 Antibodies for Botulinum Neurotoxins THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2022-03-24 US disclosed
US-11225525-B2 Antibodies for botulinum neurotoxins THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2022-01-18 US disclosed
US-10927165-B2 Antibodies that neutralize botulinum neurotoxins THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2021-02-23 US disclosed
US-20200325247-A1 Antibodies for Botulinum Neurotoxins THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2020-10-15 US disclosed
US-10618972-B2 Antibodies for botulinum neurotoxins THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2020-04-14 US disclosed
US-10611851-B2 Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2020-04-07 US disclosed
EP-1572121-A2 THERAPEUTIC MONOCLONAL ANTIBODIES THAT NEUTRALIZE BOTULINUM NEUROTOXINS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2005-09-14 EP disclosed
WO-2005016232-A2 THERAPEUTIC MONOCLONAL ANTIBODIES THAT NEUTRALIZE BOTULINUM NEUROTOXINS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2005-02-24 WO disclosed
US-20040175385-A1 Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins THE REGENTS OF THE UNIVERSITY OF CARLIFORNIA 2004-09-09 US disclosed
EP-0815125-B1 THE gC1q RECEPTOR, HIV-1 gp120 REGION BINDING THERETO, AND RELATED PEPTIDES AND TARGETING ANTIBODIES TANOX BIOSYSTEMS INC (US) 2004-06-30 EP disclosed
US-20040101780-A1 Alloy supports having recording multilayers including water insoluble and alkaline soluble polyurethanes, development inhibitors and light to heat conversion dyes, having durability and chemical resistance FUJI PHOTO FILM CO., LTD. 2004-05-27 US disclosed
EP-1418047-A2 Planographic printing plate precursor FUJI PHOTO FILM CO., LTD. (JP) 2004-05-12 EP disclosed
EP-0815125-A4 THE gC1q RECEPTOR, HIV-1 gp120 REGION BINDING THERETO, AND RELATED PEPTIDES AND TARGETING ANTIBODIES TANOX BIOSYSTEMS INC (US) 2002-01-02 EP disclosed
WO-1999055367-A9 INTERNALIZING ErbB2 ANTIBODIES UNIV CALIFORNIA (US) 2000-03-02 WO disclosed
EP-0815125-A1 THE gC1q RECEPTOR, HIV-1 gp120 REGION BINDING THERETO, AND RELATED PEPTIDES AND TARGETING ANTIBODIES TANOX BIOSYSTEMS, INC. (US) 1998-01-07 EP disclosed
WO-1996030400-A1 THE gC1q RECEPTOR, HIV-1 gp120 REGION BINDING THERETO, AND RELATED PEPTIDES AND TARGETING ANTIBODIES TANOX BIOSYSTEMS, INC. (US) 1996-10-03 WO disclosed